Edition:
United Kingdom

Intellia Therapeutics Inc (NTLA.OQ)

NTLA.OQ on NASDAQ Stock Exchange Global Market

21.94USD
22 Oct 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$21.94
Open
$22.34
Day's High
$22.38
Day's Low
$20.72
Volume
193,445
Avg. Vol
258,331
52-wk High
$35.99
52-wk Low
$16.33

Chart for

About

Intellia Therapeutics, Inc. is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known as CRISPR/Cas9. The CRISPR/Cas9 genome editing system includes two components: the Cas9 protein and the guide RNA sequence. The Cas9 protein acts like a pair of molecular scissors that... (more)

Overall

Beta: --
Market Cap(Mil.): $1,116.97
Shares Outstanding(Mil.): 36.11
Dividend: --
Yield (%): --

Financials

  NTLA.OQ Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -1.33 -- --
ROI: -17.54 0.21 14.27
ROE: -22.51 1.17 15.99

BRIEF-Intellia Therapeutics Inc Q1 Loss Per Share $0.51

* INTELLIA THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

01 May 2018

Earnings vs. Estimates